Phase I study of RG7155, a novel anti-CSF1R antibody, in patients with advanced/metastatic solid tumors.

被引：22
|
作者：
Gomez-Roca, Carlos Alberto
Cassier, Philippe Alexandre
Italiano, Antoine
Cannarile, Michael
Ries, Carola
Brillouet, Anne
Mueller, Claudia
Jegg, Anna-Maria
Meneses-Lorente, Georgina
Baehner, Monika
Abiraj, Keelara
Loirat, Delphine
Toulmonde, Maud
D'Angelo, Sandra P.
Weber, Kristy
Campone, Mario
Ruettinger, Dominik
Blay, Jean-Yves
Delord, Jean-Pierre
Le Tourneau, Christophe
机构：
[1] Inst Claudius Regaud, Dept Med, Toulouse, France
[2] Ctr Leon Berard, Dept Med, F-69373 Lyon, France
[3] CLCC Inst Bergonie, Bordeaux, France
[4] Roche Pharma Res & Early Dev Oncol, Penzberg, Germany
[5] Roche Pharmaceut Res & Early Dev, Roche Innovat Ctr Penzberg, Penzberg, Germany
[6] Roche Pharmaceut Res & Early Dev, Roche Innovat Ctr Basel, Basel, Switzerland
[7] Roche Pharmaceut Res & Early Dev, Roche Innovat Ctr Welwyn, Welwyn Garden City, England
[8] Inst Curie, Dept Med Oncol, Paris, France
[9] Inst Bergonie, Dept Med Oncol, Bordeaux, France
[10] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[11] Univ Penn, Med Ctr, Philadelphia, PA 19104 USA
[12] Canc Inst West ICO, Nantes, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.3005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3005
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I study of paclitaxel, UFT and leucovorin calcium in patients with metastatic solid tumors.
    Tkaczuk, KH
    Doyle, LA
    Tait, N
    Quinn, C
    Duckham, E
    Buadi, F
    Chen, T
    Edelman, M
    ANNALS OF ONCOLOGY, 2000, 11 : 137 - 137
  • [32] A First-in-Human Phase I Monotherapy Study of RG7212 (R), a Novel Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Solid Tumors
    Lassen, U.
    Schellens, J. H. M.
    Siu, L. L.
    Jonker, D. J.
    Sorensen, M.
    Jarutat, T.
    Wang, K.
    Gehoe, D.
    DeMario, M.
    Goss, G.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 12 - 12
  • [33] A phase I study of doxorubicin-loaded anti-EGFR immunoliposomes in patients with advanced solid tumors.
    Mamot, C.
    Ritschard, R.
    Vogel, B.
    Dieterle, T.
    Bubendorf, L.
    Hilker, C.
    Deuster, S.
    Herrmann, R.
    Rochlitz, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [34] First-in-human phase 1 study of pimicotinib (ABSK021), a CSF-1R inhibitor, in patients with advanced solid tumors.
    Falchook, Gerald Steven
    Liang, Yan
    Harvey, R. Donald
    Fu, Siqing
    Weitao, Yao
    Qin, Yan-Ru
    Zhang, Xiaojing
    Henry, Jason Timothy
    Zou, Qingping
    Shan, Boyao
    Liang, Pan
    Wang, Chen
    Li, Wenjia
    Pamuklar, Zehra Nurgul
    Pei, Yi
    Chang, Zhiwei
    Wang, Jiaqiang
    Piha-Paul, Sarina A.
    Bhave, Manali A.
    Yin, Yongmei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [35] A phase I open-label study of a novel IL-2Rβ/γ cytokine agonist, LTC004, in patients with advanced or metastatic solid tumors.
    Gong, Jifang
    Shen, Lin
    Zang, Aimin
    Zhou, Huan
    Tang, Jie
    Liu, Dan
    Jia, Youchao
    Wang, Beibei
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [36] A phase I study of safety and pharmacokinetics of NanoBB-1-Dox in patients with advanced solid tumors.
    Filon, Olga
    Krivorotko, Petr
    Kobyakov, Grigory
    Razjivina, Viktoria
    Maximenko, Olga
    Gelperina, Svetlana
    Kreuter, Joerg
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [37] Phase I study of A166 in patients with HER2-expressing locally advanced or metastatic solid tumors.
    Hu, Xichun
    Zhang, Jian
    Liu, Rujiao
    Gao, Shuiping
    Qing, Yan
    Yi, Shuli
    Yuan, Juanjuan
    Chen, Hong
    Fan, Bin
    Zheng, Haochuan
    Wang, Jingyi
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [38] A phase I study of BI 853520, an inhibitor of focal adhesion kinase (FAK), in patients with advanced or metastatic solid tumors.
    Zer, Alona
    Verheijen, Remy
    De Vos, Filip Yves Francine Leon
    Hotte, Sebastien
    Eskens, Ferry
    Pronk, Linda
    Siu, Lillian L.
    Schnell, David
    Steeghs, Neeltje
    Langenberg, Marlies H. G.
    Hirte, Hal
    De Jonge, Maja J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [39] Phase I study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors.
    Xu, B.
    Shen, L.
    Ye, D.
    Jappe, A.
    Wang, H.
    Yuan, R.
    Wu, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] A phase I study evaluating COM701 in patients with advanced solid tumors.
    Rasco, Drew W.
    Papadopoulos, Kyriakos P.
    Adewoye, Adeboye H.
    Hunter, John
    Ramsey, Denise
    ElNaggar, Adam
    Patnaik, Amita
    Vaena, Daniel A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
12345